Public Board of Directors papers 27.01.22

Infection prevention and control board assurance framework (24 December 2021 Version 1.8) – January 2022 The yellow highlights indicate a new ‘key line of enquiry’ 1. Systems to manage and monitor the prevention and control of infection. These systems use risk assessments and consider the susceptibility of service users and any risks their environment and other users may pose to them Key Lines of Enquiry Evidence Gaps in assurance Mitigating Actions Systems and processes are in place to ensure that: A respiratory season/winter plan is in place: • that includes point of care testing (POCT) methods for seasonal respiratory The trust has relevant policies that incorporates all points within the KLOE. Such policies and systems of work are agreed and

monitored through the trusts governance processes. See Management and Control of Respiratory Viruses Policy, Pandemic Flu Plan and Winter Plan 2021/2022. The policy is due to be updated but remains safe and follows current practice. With effect from 19/01/22 the trust in collaboration with Christie Pathology Partnership (CPP) introduced a combined fluA/fluB/RSV/Covid PCR which means admissions with an acute respiratory illness/flu like illness can be screened for all of these with a single swab. See Rapid Flu A/B, RSV, Covid-19 panel Test.

viruses to support patient triage/placement and safe management according to local needs, prevalence, and care services

• to enable appropriate segregation of cases depending on the pathogen. • plan for and manage

increasing case numbers where they occur. a multidisciplinary team approach is adopted with hospital leadership, estates & facilities, IPC Teams and clinical staff to assess and plan for creation of

•

C1501: Infection prevention and control board assurance framework (24 December 2021 Version 1.8) – January 2022

101